In The News Posted March 5, 2019 Share Posted March 5, 2019 KALAMAZOO, Mich., March 5, 2019 /PRNewswire/ -- Innovative Cardiovascular Solutions, LLC (ICS), a privately held medical device company, today announced the first clinical use of its next-generation Emblok™ Embolic Protection System in patients undergoing transcatheter aortic valve... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.